These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8003849)

  • 21. Inhibition of human lymphocyte cyclic nucleotide phosphodiesterases by the chlorinated adenosine analog DTA-35.
    Hurwitz MY; Hurwitz RL; Edstrom RD
    J Enzyme Inhib; 1987; 1(4):267-74. PubMed ID: 2854846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of polyphloretin phosphate (PPP) and quinterenol of cyclic nucleotide phosphodiesterase activities.
    Curtis-Prior PB; Chan YH
    Pharmacol Res Commun; 1981 Apr; 13(4):331-7. PubMed ID: 6270700
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of visnagin on cyclic nucleotide phosphodiesterases and their role in its inhibitory effects on vascular smooth muscle contraction.
    Duarte J; Lugnier C; Torres AI; Pérez-Vizcaino F; Zarzuelo A; Tamargo J
    Gen Pharmacol; 1999 Jan; 32(1):71-4. PubMed ID: 9888257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the inhibition of phosphodiesterase-catalyzed cyclic AMP and cyclic GMP breakdown and relaxation of canine tracheal smooth muscle.
    Polson JB; Krzanowski JJ; Fitzpatrick DF; Szentivanyi A
    Biochem Pharmacol; 1978 Jan; 27(2):254-6. PubMed ID: 203292
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B; Ruckstuhl M; Landry Y
    J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.
    Ahn HS; Bercovici A; Boykow G; Bronnenkant A; Chackalamannil S; Chow J; Cleven R; Cook J; Czarniecki M; Domalski C; Fawzi A; Green M; Gündes A; Ho G; Laudicina M; Lindo N; Ma K; Manna M; McKittrick B; Mirzai B; Nechuta T; Neustadt B; Puchalski C; Pula K; Zhang H
    J Med Chem; 1997 Jul; 40(14):2196-210. PubMed ID: 9216839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle.
    Silver PJ; Hamel LT; Perrone MH; Bentley RG; Bushover CR; Evans DB
    Eur J Pharmacol; 1988 May; 150(1-2):85-94. PubMed ID: 2841146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of cyclic nucleotides and their analogs and various agents on cyclic GMP-specific and cyclic AMP-specific phosphodiesterases purified from guinea pig lung.
    Davis CW; Kuo JF
    Biochem Pharmacol; 1978 Jan; 27(1):89-95. PubMed ID: 202285
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compounds.
    Ruckstuhl M; Landry Y
    Biochem Pharmacol; 1981 Apr; 30(7):697-702. PubMed ID: 6264919
    [No Abstract]   [Full Text] [Related]  

  • 31. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships.
    Van Inwegen RG; Salaman P; St Georgiev V; Weinryb I
    Biochem Pharmacol; 1979 Apr; 28(8):1307-12. PubMed ID: 87199
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
    Rybalkin SD; Bornfeldt KE
    Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of the different cyclic nucleotide phosphodiesterase isoforms separated from rat brain by flavonoid compounds.
    Picq M; Dubois M; Prigent AF; Némoz G; Pacheco H
    Biochem Int; 1989 Jan; 18(1):47-57. PubMed ID: 2541724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
    Mushlin P; Boerth RC; Wells JN
    Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
    [No Abstract]   [Full Text] [Related]  

  • 35. Do conventional plasma cyclic nucleotide phosphodiesterase inhibitors really work in all situations?
    Wood PJ; Pao G; Ross G; Smith C
    Clin Chim Acta; 1981 Sep; 115(3):405-8. PubMed ID: 6271425
    [No Abstract]   [Full Text] [Related]  

  • 36. Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment.
    Levy I; Horvath A; Azevedo M; de Alexandre RB; Stratakis CA
    Curr Opin Pharmacol; 2011 Dec; 11(6):689-97. PubMed ID: 22047791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphodiesterases and regulation of female reproductive function.
    Conti M
    Curr Opin Pharmacol; 2011 Dec; 11(6):665-9. PubMed ID: 22019564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type III cyclic nucleotide phosphodiesterases and insulin action.
    Manganiello VC; Degerman E; Taira M; Kono T; Belfrage P
    Curr Top Cell Regul; 1996; 34():63-100. PubMed ID: 8646851
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
    Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE
    Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-(4-Aminobenzyl)-and 1-(4-aminophenyl)isoquinoline derivatives: synthesis and evaluation as potential irreversible cyclic nucleotide phosphodiesterase inhibitors.
    Walker KA; Boots MR; Stubbins JF; Rogers ME; Davis CW
    J Med Chem; 1983 Feb; 26(2):174-81. PubMed ID: 6298424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.